Researchers examined alcohol-induced psychomotor performance impairments among young adult alcohol consumers with alcohol usage disorders (AUDs).
FDA explains why it rejected Vanda’s stomach drug in late 2024
Rarely does the FDA publicly release its reasoning for rejecting a potential new drug. But for DC-based Vanda Pharmaceuticals’ gastroparesis drug, the FDA on Wednesday